MedTrace Logo

Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit

NCT01332357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6139

Last updated 2017-07-06

Study results available
· View outcomes & findings →

Summary

The objective of this study is to compare readmission to the emergency department for asthma in asthma patients who receive treatment with fluticasone propionate and salmeterol oral inhaler after an initial emergency department visit using a retrospective observational cohort study design.

Conditions

Interventions

DRUG

Fluticasone propionate/salmeterol combination ED MD

Receipt of fluticasone propionate/salmeterol combination from the ED physician

DRUG

Fluticasone propionate/salmeterol combination OP MD

Receipt of fluticasone propionate/salmeterol combination from the OP physician

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-07-31
Completion
2010-07-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01332357 on ClinicalTrials.gov